Verici was incorporated in April 2020 as a wholly-owned subsidiary of Renalytix AI plc ("RENX"), the AIM-quoted developer of artificial intelligence decision support and clinical management tools for improving early diagnosis, continual monitoring and drug development for kidney disease. The Company develops tests to understand how a patient is likely and may be responding to kidney transplant.
| CEO: |
Sara Barrington |
| Non-Executive Director: |
James Renwick McCullough, Erik Kristian Lium, Lorenzo Gallon |
| Non-Executive Chairman: |
Julian Baines |
| Senior Independent Non-Executive Director: |
Ian James Carruthers |
| Address: |
Avon House, 19 Stanwell Road, Penarth, Cardiff, United Kingdom |
| Phone: |
+44 (0)29 2071 0570 |
| Fax: |
|
| Website: |
http://www.vericidx.com/ |
| Email: |
|